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ABSTRACT
Half-turns are shown to be the main determinants of many experimental Alzheimer’s 
Aβ fibril structures. Fibril structures contain three half-turn types, βαRβ, βαLβ and βεβ 
which each result in a ~90° bend in a β-strand. It is shown that only these half-turns 
enable cross-β stacking and thus the right-angle fold seen in fibrils is an intrinsic 
feature of cross-β. Encoding a strand as a conformational sequence in β, αR, αL and 
ε(βL), pairwise combination rules for consecutive half-turns are used to decode this 
sequence to give the backbone path. This reveals how structures would be 
dramatically affected by a deletion. Using a wild-type Aβ(42) fibril structure and the 
pairwise combination rules, the Osaka deletion is predicted to result in exposure of 
surfaces that are mutually shielding from the solvent. Molecular dynamics 
simulations on an 11-mer β-sheet of Alzheimer’s Aβ(40) of the Dutch (E22Q), Iowa 
(D23N), Arctic (E22G), and Osaka (E22Δ) mutants, show the crucial role glycine 
plays in the positioning of βαRβ half-turns. Their “in-phase” positions along the 
sequence in the wild-type, Dutch mutant and Iowa mutant means that the half-folds 
all fold to the same side creating the same closed structure. Their out-of-phase 
positions in Arctic and Osaka mutants creates a flatter structure in the former and an 
S-shape structure in the latter which, as predicted, exposes surfaces on the inside in 
the closed wild-type to the outside. This is consistent with the gain of interaction 
model and indicates how domain swapping might explain the Osaka mutant’s unique 
properties.
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INTRODUCTION
Amyloid arises from the aggregation of misfolded proteins and is implicated in a 
number of human diseases including Alzheimer’s Disease, Parkinson’s Disease, 
type II diabetes and Huntington’s Disease (Chiti and Dobson, 2017; Eisenberg and 
Jucker, 2012). The misfolded proteins assemble to form a fibrillar structure that is 
composed largely of β-sheet. Prior to formation of the insoluble fibre, misfolded 
proteins assemble to form a smaller, soluble structure, the amyloid intermediate 
which is known to be toxic (Kayed et al., 2003). For Alzheimer’s amyloid-β peptide 
(Aβ) there is a heterogenous “soup of oligomers” of varying sizes (Benilova et al., 
2012) and it is thought that toxicity is the consequence of some of these oligomers 
embedding in the cellular membrane, compromising membrane integrity. One 
possibility, is that toxicity is due to oligomers forming pores in the membrane that 
enable ions to pass freely, disrupting ionic balance (Arispe et al., 1993). The ability of 
Aβ oligomers to embed in membranes suggests that they could form β-barrels and 
some experimental evidence that Aβ(42) adopts a β-barrel structure within a 
membrane-like environment has been presented (Serra-Batiste et al., 2016). Jang et 
al. (Jang et al., 2010) created models of membrane embedded β-barrels based on 
the experimental structure of Aβ in the fibril state and recent molecular dynamics 
(MD) simulations revealed the formation of β-barrel motifs in an Aβ(42) trimer 
derived from a solution structure of the monomer (Nguyen et al., 2020). 
For the fibrils themselves, early X-ray fibre diffraction experiments on amyloid fibrils 
indicated a cross-β structure (Sunde and Blake, 1998), that is the β-strands run 
perpendicular to the fibril axis, and numerous atomic structures of fibrils of Aβ(40) 
and Aβ(42) solved mainly using solid-state NMR(Colvin et al., 2016; Gremer et al., 
2017; Luhrs et al., 2005; Schutz et al., 2015; Sgourakis et al., 2015) have their β-
strands in this arrangement. The existence of cross-β has effectively become a 
defining characteristic of amyloid fibrils (Ke et al., 2020) and although there is a great 
deal of polymorphism within Aβ fibrils (Fandrich et al., 2009; Meinhardt et al., 2009), 
there seems to be only one experiment where a violation of this apparent rule was 
found. X-ray fibre diffraction experiments performed by Fraser et al. (Fraser et al., 
1992) on human Aβ(40) fibrils found that the strands were tilted by 36° to the usual 
perpendicular arrangement of cross-β. Further work by Malinchik et al. (Malinchik et 
al., 1998) suggested a model whereby a fibril comprises three to five tubular 
protofilaments, each of ~30 Å diameter with tilted arrays of β-chains. A weak 
meridional reflection at 57 Å suggested to Fraser et al. (Fraser et al., 1992) that there 
might be a 12-strand axial repeat present. Hayward and Milner-White (Hayward and 
Milner-White, 2017) used an extension of the theory of the shear number in β-barrels 
for application to homomeric helical β structures, to present a model of the 
protofilament subunit which comprises a parallel β-sheet formed from in-register 
strands curled up such that the outer strands join with β-sheet hydrogen bonding, but 
with a register shift. This “β-strip helix” has qualities of both β-helix and β-barrel 
structures. The estimated diameter of the protofilament, and the tilt angle of the 
strands from Fraser et al. were used to determine the number of strands and the 
register shift at the join between the outer strands of a β-strip helix model (Hayward 
and Milner-White, 2017; Hayward and Kitao, 2019). The calculation gave 11 strands, 
one less than estimated by Fraser et al. from the axial repeat distance, and a register 
shift of 22 residues. The resulting structure is β-barrel-like with the same tilt angle 
and diameter as the transmembrane β-barrel, TolC in Escherichia coli, suggesting 
that it could be a candidate for the toxic oligomeric intermediate. This model has a 
further attractive feature in that the protofilament can form from these β-strip helices 
as protofilament subunits, joining end-to-end with the same register shift at the join 
between subunits as at the join between the outer strands stabilising each individual 
β-strip helix subunit (Hayward and Kitao, 2019). This same principle applies to the 
amyloid fibril of the HET-s(218-289) prion (Wasmer et al., 2008), which employs a 
tandem pseudo repeat sequence with the appropriate register shift for stabilising 
both the join within each individual β-helix subunit and the join between β-helix 
subunits forming the fibril (Hayward and Milner-White, 2017).
In order to investigate the feasibility that 11 in-register chains of wild type (WT) 
Aβ(40) form a stable β-strip helix, multiple MD simulations were performed starting 
from parallel β-sheets comprising 11 perfectly straight strands forming an untwisted 
β-sheet of Aβ(40) chains (Hayward and Kitao, 2019). Despite some variation in 
starting conditions and terminal groups, all the structures folded up to form closed 
structures that were remarkably similar to the experimentally derived β-strip helix 
model based on the measurements of Fraser et al.. All final structures, which had a 
general helical form with some disorder at the outer edges and ends, had diameters 
in the range 28-35 Å and tilt angles in the range 35-37°, comparing very favourably 
to the experimental values of 30 Å and 36°, respectively. Contacts between the outer 
strands were distributed around the expected register shift of 22, although there was 
not extensive β-sheet hydrogen bonding between the outer strands. MD simulations 
were also performed on 10- and 12-strand sheets, but these did not form closed 
helical structures. However, the C-terminal region of the final 12-strand structure did 
resemble the structure of Aβ(42) by Lührs et al., (Luhrs et al., 2005) determined 
using NMR techniques. These results suggest something unique about the 11-mer. 
A criticism of this approach might be that the starting structures for the MD 
simulations are non-physical. Formation of an 11-mer will involve a complex process 
of interaction between existing smaller oligomers of various sizes and morphologies. 
However, accepting that the true 11-mer structure is at a reachable global free-
energy minimum from a nearby conformation of higher free energy, starting with a 
structure that incorporates as much as we know (11 in-register strands forming 
predominantly β-sheet), without biasing it in any way (perfectly straight strands 
forming a flat untwisted β-sheet), would seem reasonable. At the very least the final 
structures should reveal local variations in structure that disrupt β-sheet hydrogen 
bonding and so possibly tell us how these structural variations relate to local 
sequence composition.
Here we study four familial mutations at, or close to, Glu22 of Aβ(40) that can cause 
early-onset Alzheimer’s disease and cerebral amyloid angiopathy (CAA). As Glu22 is 
central to Aβ(40) and Aβ(42) mutations at this site that alter the conformation locally 
are likely to have a global effect. Immunological assays support the hypothesis that 
single mutations at Glu22 of Aβ(40) cause conformational change within the 
emerging aggregates that lead them to be more toxic (Hatami et al., 2017). The four 
mutations studied are Dutch (E22Q), Iowa (D23N), Arctic (E22G), and Osaka (E22Δ, 
deletion mutation). The Dutch and Iowa Aβ40 mutants have been shown to have an 
enhanced rate of fibril formation compared to the WT (Van Nostrand et al., 2001) 
and both cause severe CAA. The Arctic Aβ40 mutant also has an increased rate of 
protofibril formation in comparison to the WT, and it has been suggested that it 
produces Alzheimer’s disease through an alternative pathogenic mechanism 
(Nilsberth et al., 2001), perhaps due to its high degree of polymorphism (Elkins et al., 
2016). In vitro experiments have found that the Osaka Aβ40 mutant forms a large 
network of fibrillar bundles rather than the straight fibrils seen with the WT 
(Ovchinnikova et al., 2011). However, in vivo analyses have shown that although it 
oligomerises more readily than the WT, fibrils do not form at all (Shimada et al., 
2011; Tomiyama and Shimada, 2020; Tomiyama et al., 2008).
In this study we continue the approach we took previously for WT Aβ(40). We 
performed explicit-solvent MD simulations starting from flat, untwisted 11-strand β-
sheet structures of Dutch, Iowa, Arctic, and Osaka Aβ(40) mutants to determine the 
effect of these mutations on the resulting structures in comparison to our previous 
WT simulation results. The analysis of the results of these MD simulations made us 
aware of the importance of glycines and the impact of half-turns in determining the 
overall shape of the final structure. This led to an analysis of half-turns found in 
deposited structures of the Aβ fibril. Half-turns have the conformational sequence  
βαRβ, βαLβ or βεβ and produce an approximately 90° change in direction of the 
strand (Efimov, 1993). In the context of β-solenoids, where like here, β-strands in 
parallel are interrupted by turns, these turns have been called “β-arcs” (Hennetin et 
al., 2006). Here we show that the in-register occurrence of a half-turn on each strand 
of a β-sheet creates a ~90° fold in the sheet and that this right-angle fold is an 
intrinsic feature of the cross-β structure. We also show that pairwise combination 
rules for the three different types of half-turns determine the general path of the 
backbone in cross-β fibril structures. This demonstrates how the deletion of the 
Osaka mutant dramatically alters its structure compared to the wild-type.
METHODS
MD simulations
All MD simulations were performed by AMBER16 (D.A. Case et al., 2016). Starting 
structures were perfectly flat β-sheets comprising 11 straight strands prepared using 
the process described previously (Hayward and Kitao, 2019), which involved use of 
the SCWRL4 program (Krivov et al., 2009) for placement of side chains. Charged 
groups, NH3 and COO were used for the N- and C-termini, respectively, for all 
simulations. The AMBER ff14SB force field was used for the peptides (Maier et al., 
2015). All boxes were cubes in order to minimize possible artefacts caused by the 
reorientation of the peptides during a long MD simulation. The SPC/Eb model 
(Takemura and Kitao, 2012) was used for water and Joung-Cheatham parameters 
(Joung and Cheatham, 2008) for KCl ions which were distributed in the box to 
neutralise it and impose 0.14 M ionic strength on the system. After energy 
minimization, 5 ns of MD simulation was performed with positional restraints 
imposed on N, Cα, and Cʹ by gradually weakening the force constant from 1.0 to 0.01 
kcal/molÅ2. All MD simulations were performed using the GPU implementation of 
Pmemd module (Le Grand et al., 2013). Isothermal-isobaric conditions were 
achieved by a Langevin thermostat (Sindhikara et al., 2009) and a Berendsen 
barostat (Berendsen et al., 1984). Equations of motion were integrated with a time 
step of 2 fs. The long-range Coulomb energy was evaluated using the particle mesh 
Ewald method (Essmann et al., 1995). After restraints were released, MD simulation 
without restraints was conducted for 1 μs, and the generated trajectories were used 
for the analysis. 
Contour plots and model structures
The basic modelling methods used here are described in Hayward and Milner-White 
(Hayward and Milner-White, 2008). The standard bond lengths and bond angles 
used are given in Table 1 of that article. Modelling involved use of rotation matrices 
and translation vectors enabling transformation between coordinate systems situated 
on different atoms. The Ramachandran contour plots in Figure 6 are based on two 
quantities,  and . We vary the ,  angles of the residue at the bend and keep 𝑆𝑃 𝑆𝐵
the ,  angles of all other residues at the ideal straight β-strand values of -
120°,115.8°. We denote the two strands flanking the bend, β1 and β2, and the unit 
vectors along their helical axes as  and , respectively.  and  were  𝒏𝜷𝟏 𝒏𝜷𝟐 𝒏𝜷𝟏 𝒏𝜷𝟐
determined at each ,  point on the Ramachandran plot for the residue at the bend 
(Hayward and Milner-White, 2008). This means we can calculate, , the unit 𝒏𝜷𝟏𝟐
vector perpendicular to the plane defined by the helical axes of β1 and β2 by 
evaluating the cross product of  and . The unit vectors,  and , each 𝒏𝜷𝟏 𝒏𝜷𝟐 𝒏𝒑𝒑𝟏 𝒏𝒑𝒑𝟐
perpendicular to a selected peptide plane on β1 and β2 respectively, were also 
calculated. As a β-strand with the angles (-120°,115.8°) forms an untwisted flat 
ribbon –  the number of residues per turn being exactly two – if any one peptide 
plane on a strand is perpendicular to the plane defined by the helical axes of the two 
strands, then so will all peptide planes on that strand. Thus, the unit vectors,  ± 𝒏𝒑𝒑𝟏
and  represent all peptide planes on β1 and β2, respectively. , which is a ± 𝒏𝒑𝒑𝟐 𝑆𝑃
function of , , of the residue at the bend was evaluated as:
(1)𝑆𝑃 = (𝒏𝒑𝒑𝟏 ∙ 𝒏𝜷𝟏𝟐)2 + (𝒏𝒑𝒑𝟐 ∙ 𝒏𝜷𝟏𝟐)2
where the dot indicates the scalar product.  will only be zero if  and  are 𝑆𝑃 𝒏𝒑𝒑𝟏 𝒏𝒑𝒑𝟐
both perpendicular to  which would mean both sets of peptide planes are 𝒏𝜷𝟏𝟐
perpendicular to the plane defined by the two strands. 
, which quantifies the angle between the two strands was evaluated as:𝑆𝐵
(2)𝑆𝐵 = (𝒏𝜷𝟏 ∙ 𝒏𝜷𝟐)2
Values of ,  for which  are where there is a 90° bend. 𝑆𝐵 = 0
Poly-alanine structures shown in Figure 7 were produced using an in-house 
program. Structures shown in Figure 7(D-F) were created by docking two individual 
strands using the interactive docking tool, DockIT (Iakovou et al., 2020) 
(www.haptimol.co.uk). Images of structures presented in Figures 2, 4, 7 and 8 were 
produced using PyMol (www.pymol.org). 
RESULTS 
RMSD calculations on trajectories
We compare the mutant trajectories to the WT trajectory “11_cube_C_charge” from 
our previous work (Hayward and Kitao, 2019). Figure 1 shows RMSD “colour-maps” 
between the WT and each mutant over their whole 1 μs MD simulation trajectories. 
These maps enable one to compare the folding process of each mutant to that of the 
WT. These clearly show that early in the folding process the Arctic and Osaka 
mutant display radically different behaviour with their structures diverging rapidly 
from that of the WT.  This is particularly the case for the Osaka mutant. These plots 
suggest that the Dutch and the Iowa mutants fold to a similar structure to the WT. 
However, the Dutch mutant folds more slowly, only reaching structures similar to the 
WT final structure after about 600 ns. 
RMSD calculations of final structures
Here we compare the final WT structure to the final mutant structures. Table I gives 
the RMSD between each final mutant structure and the final WT structure. Figure 2 
shows the WT final structure and the final mutant structures. It is immediately clear 
that the Dutch and Iowa final structures are very similar to the WT final structure, but 
that the Arctic and Osaka final structures are dramatically different to it. The N-
terminal regions (residues 1-21) of all the mutants, which form multi-strand partial β-
barrels, have relatively low RMSD’s (see Table 1) with the WT. In all structures 
including the WT, the C-terminal region is more disordered. Table 1 gives the 
RMSD’s between the C-terminal region (residues 23-40) of the mutants and the WT, 
which are larger than for the N-terminal region primarily because this region is more 
disordered. For the Dutch and Iowa mutants, like the WT, their C-terminal regions 
fold onto the inside surface as defined by the N-terminal partial β-barrel to maintain a 
structure that can be generally described as a right-handed multi-strand helix. Thus, 
the structure forms a β-barrel-like structure overall with a somewhat more disordered 
C-terminal region. The Arctic and Osaka mutants have a different morphology in 
their C-terminal regions. In the Arctic mutant, the C-terminal region does not fold to 
the right (in a helical sense) but the strands fold inwards without any lateral 
movement, e.g. much like the fingers in a hand would. The Osaka mutant the C-
terminal region folds to contact the outside surface defined by the partial β-barrel 
formed by the N-terminal region. Figure 2(F) clearly illustrates the dramatic 
difference between the WT and the Osaka mutant. 
Analysis of ,  angles of final structures
In all simulations there is little change in conformation during the final 100 ns (see 
Fig S1). Thus, in order to compare the ,  angles of individual residues between the 
different variants in the final structures, we averaged – taking periodicity of angles 
into account – each residue’s  and  angles over the frames in the final 100 ns of 
the simulation, and also over chains C-I, that is not including the outer two chains on 
both sides, which have rather irregular conformations. Figure 3 shows that the Dutch 
and Iowa mutants have ,  angles that are very close to those of the WT apart from 
the final four residues at the C-terminus. For the Arctic and Osaka mutants their ,  
angles are very close to those of the WT over the N-terminal region (residues 1-20) 
but differ appreciably at particular residues within the C-terminal region. For all it is 
noticeable from Figure 3 that the change in angles from the starting structures is 
appreciable at and around Gly9, Gly25, and Gly29, as well as Gly22 for the Arctic 
mutant. They all show an appreciable change in the  angle of the Pre-gly from that 
of a β-sheet. If we denote the Pre-gly position as i then typical (, ) values are (-
130°,120°)i-1, (-115°,-20°)i, and (-70°,140°)i+1. 
The “half-fold” in WT, Dutch and Iowa
The conformational sequence based on the Ramachandran plot regions can be 
denoted as β(i-1)αR(i)β(i+1), as the Pre-gly(i) is in the general right-hand α-helix 
region, αR, and the residue at i-1 and the Gly(i+1) are in the general β region. If we 
use the finer classification of (, ) angles in the Ramachandran plot given by Efimov 
(Efimov, 1993), then this conformational sequence would be ββP where  denotes a 
subregion of the αR region centred on (-90°,0°), and βP is the polyproline II region. 
With standard angles βαRβ produces a “half-turn” (Efimov, 1993) where there is a 
~90° change in the strand direction, but the ββP half-turn produces a ~60° change in 
strand direction. This half-turn can also be regarded as a β-bulge, in particular the 
“P-bent” class of β-bulge, defined by Chan et al. (Chan et al., 1993) and a type of β-
arc (Hennetin et al., 2006). As seen in Figure 4, which shows the feature in the WT 
structure, the bifurcated hydrogen bonds to Pre-gly(i) and Gly(i+1) are with the 
carbonyl group of residue i-1 on the neighbouring chain. It seems for this motif a 
Gly(i+1) is necessary as a side chain would be oriented to clash with neighbouring 
chains. The in-register arrangement of chains, means the alignment of glycines 
across the sheet and consequently the alignment of the half-turn. In the WT, Dutch 
and Iowa structures this results in half-turns in the sheet at Gly9, Gly25, and Gly29. 
We refer to a half-turn repeated across in-register chains as a “half-fold”. 
A β-sheet has two sides and the side chains alternate between each side as one 
moves along a strand from one residue to the next. A half-fold at any one of the 
positions i, i+2, ···, would cause the same side of the β-sheet to be on the inside of 
each fold, whereas a half-fold at any one of the positions i+1, i+3, ···, would cause 
the opposite side of the β-sheet to be on the inside of each fold, i.e. they fold to 
opposite sides of the sheet. In the WT, Dutch and Iowa structures, Gly9, Gly25, 
Gly29, Gly33 and Gly37, are at odd number positions (see Figure 5). This “in-phase” 
arrangement means half-folds at these locations would all fold the sheet to the same 
side. A β-sheet has a natural tendency to curl up with the strands forming right-
handed helices. This is due to the natural tendency for a β-sheet to have a right-
handed twist (Chothia, 1983) and can be clearly seen in the early stages of our 
folding simulations. This natural tendency means the strands in β-barrels always 
form right-handed helices. It is significant that the half-folds at Gly9, Gly25 and Gly29 
in the WT, Dutch and Iowa structures all aid in the formation of a closed cylindrical 
structure by accentuating the natural curling of the sheet. This ability to accentuate 
the natural twist seen in a β-sheet was a feature noted by Chan et al. (Chan et al., 
1993) in their study of β-bulges. 
These considerations explain the general form of the WT, Dutch and Iowa structures 
and suggest an explanation for the Osaka and Arctic mutants forming such different 
structures. As we describe below, their structures can be explained by the “out-of-
phase” positioning of the half-folds at the Gly locations in these mutants.
Effect of half-fold in Arctic
The Gly22 in the Arctic mutant means we have glycines at positions 9, 22, 25, 29, 
33, 37 and 38. All of these are in phase apart from Gly22 and Gly38. The effect of a 
half-fold at Gly22 would be expected to fold the sheet to the opposite side to that 
formed by the N-terminal region before it is refolded back to the same side as the N-
terminal region by half-folds at Gly25 and Gly29 (see Figure 5). This is generally 
what we observe as the sheet has two inwardly folded regions separated by an 
outwardly folded kink at Gly22 (see Figure 2(D)).  Although the half-fold at Gly29 
shows a good array of bifurcated hydrogen bonds across the sheet, there is some 
disruption of this feature at Gly22 and Gly25. This is particularly the case for Gly25 
where a number of neighbouring chains on one side of the sheet have a more 
conventional β-strand configuration, whereas for the opposing set of neighbouring 
chains, the effect of the half-fold is plain to see.
Effect of half-fold in Osaka
The Osaka mutant has a deletion at Glu22. Thus far, we have used the WT 
numbering to label the residues in the Osaka mutant, but if we use the actual 
number in the sequence then we have glycines at positions 9, 24, 28, 32, 36 and 37. 
Although the glycines at positions 24, 28, 32 and 36 are in phase, as a group they 
are out of phase with Gly9. This means a half-fold at any one of these, will fold the 
sheet to the opposite side to the half-fold at Gly9. What is more, they will fold to the 
opposite side created by the natural curl of the sheet. In the Osaka mutant, half-folds 
form early in the folding process particularly at Gly24 and Gly28 which causes the 
sheet to fold to the opposite side of the sheet to the natural curl and the half-turn at 
Gly9 (see Figure 5). This gives it its characteristic “S-shape” as seen in Figure 2(E). 
Early in the folding process there is an array of bifurcated hydrogen bonds at Gly24 
and Gly28 but later in the process some of the peptide planes between the Pre-gly 
and Gly24, and the Pre-gly and Gly28 have rotated to disrupt these hydrogen bonds. 
However, the overall S-shape formed in the early stages of folding remains. 
Half-folds in previous simulations on WT Aβ40 with 10-, 11- and 12-strands
In our previous work we did a number of MD simulations on the Aβ40 WT with 10-, 
11- and 12-strands. We performed four independent simulations with 11-strands, 
each with a different starting structure, box shape or terminal groups (Hayward and 
Kitao, 2019). We also performed simulations on sheets formed from 10- and 12- 
strands. Re-analysis of the results of those simulations revealed  half-folds at Gly9, 
Gly25 and Gly29. The C-terminal half of the 12-strand final structure bore 
resemblance to the solid-state NMR structure of Luhrs et al. (Luhrs et al., 2005) 
(PDB: 2BEG) .  If we had performed simulations on the same mutants but with 
different size oligomers, results suggest that we would see similar effects due to the 
fact that the phasing of the half-turns is dependent on the positions of the glycines 
along the in-register chains and not on the number of strands. 
Half-folds in experimental Aβ fibril structures
We analysed the following structures of the Aβ fibril deposited in the (Protein Data  
Bank) PDB: the WT structures of Luhrs et al. (Luhrs et al., 2005) (PDB: 2BEG), 
Colvin et al. (Colvin et al., 2016) (PDB:5KK3), Gremer et al. (Gremer et al., 2017)  
(PDB: 5OQV) and Xiao et al. (Xiao et al., 2015), the structure of the Iowa mutant of 
Sgourakis et al. (Sgourakis et al., 2015) (PDB: 2MPZ), and the Osaka mutant of 
Schutz et al. (Schutz et al., 2015) (PDB: 2MVX). All of these, apart from the 5OQV 
structure, which was determined mainly using cryo-electron microscopy (cryo-EM), 
have been solved using NMR techniques, often solid-state NMR. All are formed from 
parallel β-sheet with their chains in-register. The in-register arrangement, combined 
with the cross-β configuration, means the path of the backbone of each individual 
chain can be approximately represented by a single backbone trace confined to the 
two dimensions perpendicular to the fibril axis. Although there is a great deal of 
polymorphism within the 2D shapes that the backbones of the deposited structures 
trace, most have one thing in common: they have straight β-strands interspersed by 
turns (in the general sense of the word) that change the path of the chain by ~90° 
(see backbone traces in Figure 8). By averaging the main chain dihedral angles over 
the chains and models in each PDB file we were able to assign most of the turns to a 
βαRβ, βαLβ or βεβ half-turn, where the ε conformation (also referred to in the 
literature as βL) is in the lower right-hand region of the Ramachandran plot (Efimov, 
1993). According to Efimov (Efimov, 1993) half-turns change the strand direction by 
~90° and so the half-turns we see in the experimental fibril structures are closer to 
the Efimov half-turn than the ββP half-turn seen in the simulations.
Special properties of half-turns enable cross-β stacking
We ask the following question: Is there a relationship between the half-turn and the 
cross-β arrangement of strands? In other words, is the half-turn the only type of turn 
that allows the cross-β stacking of strands? For stacking via β-sheet hydrogen 
bonding to occur, the peptide planes must be perpendicular to the plane that a bent 
strand creates. Any other arrangement would not result in a fibril in the cross-β 
configuration. The Ramachandran contour plot shown in Figure 6(A) demonstrates 
that only these three half-turns give β-strands with their peptide planes perpendicular 
to the plane of the bent strand. Figure 6(B) shows that these three half-turns result in 
an ~90° bend. Thus, there is a relationship between the cross-β configuration, and 
the right-angle turns seen in the 2D path taken by individual chains.
In order to investigate half-turns more closely we created model structures with the 
(, ) angles (-70°, -70°), (70°, 70°) and (150°, -150°), for the αR, αL and ε 
conformations, respectively, the locations of which are indicated in Figure 6 on the 
Ramachandran contour plots. We attempted to dock two model half-turn poly-alanine 
strands of each type using the interactive docking tool, DockIT (Iakovou et al., 2020), 
which is able to show hydrogen bonds as they form. As shown in Figure 7 (D), (E) 
and (F) the bent strands can be brought together such that all main-chain hydrogen 
bond donors and acceptors are satisfied by hydrogen bonds. For the βεβ half-turn 
strand this could only be achieved with a glycine in the ε conformation, necessary 
anyway for this conformation (Richardson and Richardson, 1989). These features 
show how the special characteristics of half-turns enable chains from separate 
molecules to stack in the cross-β configuration without loss of inter-strand main-
chain hydrogen bonding to build protofilaments containing half-folds.
Pairwise combination rules for half-turns
In half-turns the direction of turn can be found using the following rule: point the 
thumb of corresponding hand (right for βαRβ; left for βαLβ and βεβ) in direction of N-
H at residue i-1 (first β residue) and the curl of fingers gives direction of turn (see 
Figure 7(A), (B) and (C). The βαRβ and βαLβ half-turns produce a change of phase in 
the orientation of the peptide planes in that if the N-H bond of residue i is pointing 
upwards, then the N-H of the following residue at i+1 will also point upwards, 
whereas for the βεβ half-turn the peptide planes continue to alternate in orientation 
(see Figure 7). Note that the βεβ half-turn has a less abrupt 90° bend than the βαRβ 
and βαLβ half-turns and the repeating dipeptide …βεβεβε… forms a ring structure, 
called the “unpleated β”(Hayward et al., 2014). Table 2 summarises the effect of the 
three different types of half-turns.
Consideration of handedness of half-turns and the change in phase of the orientation 
of the peptide planes leads to a set of rules for pairs of half-turns in β-strands. A pair 
of consecutive half turns can either produce a “reversal” as shown in Figure 7(G) or 
a “crankshaft” as shown in Figure 7(H). In general, reversals are produced by αR…αR 
or αL…αL separated by an even number of β residues, or by αR…αL and αL…αR, 
separated by an odd number of β residues. Crankshafts are produced by αR…αR or 
αL…αL, separated by an odd number of β residues, or by αR…αL and αL…αR, 
separated by an even number of β residues. Considering all three half-turn types, 
there are 18 possible pairwise combinations of half-turns; Table 2 shows which 
produce reversals, and which produce crankshafts. Note the rules for the αR pairs do 
not apply to the ββP half-turn found in the simulations due to its very different 
nature.
Note that if we have βαRαLβ or βαLαRβ or longer sequences of alternating αR and αL 
conformations then this is an α-strand as found in α-sheet (Daggett, 2006; Hayward 
and Milner-White, 2008; Milner-White et al., 2006; Pauling and Corey, 1951), a 
secondary structure implicated in the formation of the amyloid intermediate (Hayward 
and Milner-White, 2021; Shea et al., 2019). Like β-strand, α-strand is straight, but 
unlike the β-strand all N-H bonds point in the same direction. 
Half-turn sequence representation of backbone traces of experimental Aβ fibril 
chains
We have assigned each residue in the six experimental structures analysed to one of 
either a β, αR, αL, or ε. Figure 8(A) shows the alignment of these conformational 
sequences. As can be seen the conformational sequence can be written in a 
condensed form. For the Iowa mutant, 2MPZ, the sequence is “10L1R13”, which 
means, starting from the N-terminus, there are 10 β residues, followed by one αL 
residue, followed by one β residue, followed by one αR residue, followed by 13 β 
residues. Using this “half-turn sequence” we can use the rules in Table 2 to produce 
a simplified path of the backbone. For each of the six structures studied, Figure 8(B-
G) shows the half-turn sequence derived model in comparison to the backbone 
trace. As can be seen the half-turn sequence model follows closely the actual 
backbone trace in most cases, although as explained in the legend to Figure 8 for 
two cases the half-turn sequence model produces an overlapping structure and 
some adjustment is needed for it to follow the true backbone trace. 
Modelling the Osaka mutant from the WT
A deletion will result in an odd number of intervening β residues becoming even, or 
vice-versa, which will mean a reversal becoming a crankshaft, or a crankshaft 
becoming a reversal (see Table 2). The effect of a deletion can be understood 
clearly by appreciating that it is the equivalent to the transformation required to fit a 
residue at i to the previous residue at i-1 in a β-strand. This transformation is a ~180° 
rotation about, and a -3.3 Å translation along, a screw axis co-linear with the strand 
pointing in the positive strand direction. This transformation produces a crankshaft 
from a reversal or vice-versa.
The structure 5OQV of Aβ1-42 is a full-length structure of the WT peptide 
determined to 4Å resolution with cryo-EM complemented by solid-state NMR. It has 
the half-turn sequence of 9L12L1R8L2L5 and the half-turn sequence model is shown 
in Figure 9(A). For the Osaka mutant structure, the deletion of Glu22 results in the 
half-turn sequence 9L11L1R8L2L5. Thus, the reversal L12L in the WT structure 
becomes the crankshaft L11L in the Osaka mutant. Figure 9(A) also shows the half-
turn sequence model of the predicted Osaka mutant whereby the C-terminal side is 
rotated and translated by the deletion to produce a crankshaft rather than a reversal. 
Although this structure does not resemble the Osaka mutant structure of Schutz et 
al. (Schutz et al., 2015) (PDB: 2MVX) (see Figure 8(D)), the effect of the mutation is 
similar to what we have seen in the simulations in that the closed curled-up WT 
structure now has surfaces that were on the inside of a closed structure exposed to 
the outside. In this case two hydrophobic surfaces that mutually shield each other 
from the solvent in the WT are exposed in the predicted Osaka mutant. Figure 9(B) 
illustrates protofilaments that join together to shield the two surfaces, each now from 
a different protofilament. This process of association may offer a plausible 
explanation for the different oligomerisation behaviour of the Osaka mutant 
compared to the WT.
DISCUSSION
The motivation for performing simulations on Aβ(40) mutants was to compare results 
to the simulations performed previously on WT Aβ(40) (Hayward and Kitao, 2019). 
The WT 11-mer formed a structure with dimensions almost exactly matching those of 
the 11-strand β-strip helix predicted from X-ray fibre diffraction experiments by 
Fraser et al. (Fraser et al., 1992). A β-strip helix has aspects of both a β-helix and a 
β-barrel, and its similarity to the latter indicates that it could embed in membranes as 
suggested for the toxic oligomeric intermediate. Its similarity to the former could also 
explain how a protofilament could form from β-strip helices joining end-to-end in the 
same way as in the HET-s(218-289) prion, although such a structure would be an 
exceedingly rare fibril polymorph in not having the cross-β configuration. Such a 
protofilament would have a β-strip helix repeat distance of ~60 Å (Hayward and 
Milner-White, 2017; Hayward and Kitao, 2019) which is close to the 57 Å (Fraser et 
al., 1992) axial repeat distance suggested by a weak meridional reflection, a quantity 
not used for the modelling of the 11-strand β-strip helix. Fraser et al. suggested this 
might be due to a 12-strand repeating unit, but this would not be consistent with the 
off-meridional 4.7 Å reflection, suggesting the strands were tilted by 36° to the 
perpendicular. There is evidence that a 12-mer soluble oligomeric species of Aβ(42) 
causes memory loss in a transgenic mouse model (Lesne et al., 2006). This species 
of oligomer was referred to as Aβ*56, 56 kDa being the molecular weight of the 12-
mer. However, the results of that study would also seem not to be able to definitively 
exclude the possibility of an 11-mer. This begs the question – why is evidence for the 
11-strand β-strip helix not seen by others as a fibril component? Fraser et al. found 
their WT fibril was not stable in aqueous solution compared to other fibrils that 
presented the standard cross-β 4.7 Å reflection on the meridian, requiring special 
treatment to stabilise it. This makes sense as the cross-β configuration maximises 
inter-subunit hydrogen bonding with even those residues at the folds participating in 
main-chain hydrogen bonding, whereas the protofilament built from 11-strand β-strip 
helices has an inherent weakness at the join between the β-strip helices, where 
maximally only 18 (18=40-22, where 22 is the register shift) of the 40 residues 
participate in β-sheet hydrogen bonding. This may suggest that only oligomers that 
are in the cross-β configuration emerge from the “oligomeric soup” (Benilova et al., 
2012) as fibrils, but those that are non-cross-β are too weak to under most 
environmental conditions. However, they may be good candidates for the toxic 
oligomeric intermediate, especially if they have characteristics of transmembrane β-
barrels.
Despite the considerable differences between the 11-strand β-strip helix model and 
the deposited cross-β fibril structures, our simulations have revealed features that 
they have in common, namely half-turns. Previously we noted the bends in the β-
strands at glycines in the 11-mer structure (Hayward and Kitao, 2019), but this was 
not explored further. These disruptions were also seen in 10-mer and 12-mer 
structures from our previous simulations (Hayward and Kitao, 2019). Here further 
analysis has shown them to be half-turns of the form βαRβ, more specifically ββP, 
with the glycine at the βP position. The ββP half-turn is somewhat different to the 
βαRβ half-turn seen in the experimental Aβ fibril structures, in that the latter produces 
an approximately 90° change in direction of the strand, whereas the former gives an 
approximately 60° change in strand direction.  The in-register arrangement of the 
chains means the half-turn is generally repeated across the chains to form what we 
have called a “half-fold”. A recurring glycine is found at the second β position in a 
half-fold, that runs along one corner of the triangular β-helix in the fibril-like tail spike 
of T4 phage (van Raaij et al., 2001), indicating that our finding is not an artefact of 
simulation.  
As we have demonstrated, the half-turns in the deposited cross-β structures are of 
three types: βαRβ, βαLβ and βεβ. Using the nomenclature of β-arcs (Hennetin et al., 
2006), these turns would be denoted as ba, bl and beb, respectively. These β-arcs 
are the shortest of the β-arcs types. Significantly, their hydrogen bond donor and 
acceptor groups can also participate in inter-strand hydrogen bonding adding more 
stability to the fibril than would be the case with longer β-arcs. That half-turns 
produce a ~90° fold in a β-sheet means that this right-angle fold commonly seen in 
Aβ fibril structures is an essential feature of the cross-β configuration.
The βαLβ (more specifically, βPαLβP) turn has been found to occur at the corners in 
left-handed β-helices with the equilateral prism fold (Iengar et al., 2006), but analysis 
of sequence features found glycine to occur at the first βP position rather than the 
second. Certainly, glycine is required for the ε conformation in the βεβ half-turn.  
Figure 8(A) suggests that there is a connection between glycine location and the 
occurrence of at least some of the half-folds in the deposited fibril structures. It is 
intriguing to realise that the glycines are positioned to be in-phase for the βαRβ fold 
in the WT and that this in-phase relationship means that for the WT, as well as the 
Dutch and Iowa mutants, the half folds all fold to the same side creating a closed, 
curled-up structure. Thus our conclusion would be that for the Dutch and Iowa 
mutants there is little impact on the fundamental structural component of Aβ(40) 
oligomers and the effect of these mutations may lay elsewhere, perhaps by affecting 
aggregation rate (Chiti et al., 2003).
For the Arctic mutant the presence of Gly22 means there is an out-of-phase glycine 
causing it to fold outwardly until it is refolded back inwardly by Gly25 (see Figure 5). 
This produces a kink in the structure which due to its central location, results in a 
structure that is generally flatter than the WT structure. This makes the structure 
more exposed to the solvent compared to the WT, possibly explaining the enhanced 
rate of protofibril formation seen for the Arctic mutant (Nilsberth et al., 2001) through 
a process that shields exposed hydrophobic residues through subunit association. 
Changes of this type that lead to protofilament formation have been called the “gain 
of interaction” (Elam et al., 2003; Nelson and Eisenberg, 2006).
For the Osaka mutant the effect of the deletion of Glu22 is to put the Gly25 and 
Gly37 out of phase with Gly9 and to cause the sheet of the C-terminal side to fold to 
the opposite side to the N-terminal side giving it an “S” shape (see Figure 5). This 
will put the side that is originally on the inside of the closed WT structure on the 
outside, and vice-versa. This is another example of the gain of interaction model.
Due to their cross-β structure, the backbone traces of the deposited structures of Aβ 
are largely restricted to 2D. In many cases the structures comprise β-strands 
interspersed by half-turns of which there are three types: βαRβ, βαLβ and βεβ. We 
have shown, the main-chain conformational sequence can be decoded using 
pairwise combination rules for consecutive half-turns to give the trace of the 
backbone. As seen from Table 2, the effect of a single deletion in a β-strand between 
two half-turns would, all else remaining the same, cause a reversal to become a 
crankshaft or vice-versa. This will have a dramatic consequence if, in the case of a 
reversal, the two inside surfaces are shielding each other from the solvent. We used 
the full N- to C-terminal structure of the WT fibril of Aβ(42) solved to a relatively high 
4 Å resolution using cryo-EM (Gremer et al., 2017) to model the effect of the Osaka 
mutation. This structure has interdigitating side chains within a single protofilament 
producing a so-called “steric zipper” arrangement (Nelson and Eisenberg, 2006).  
Based on the pairwise combination rules, the deletion of Glu22 turns a reversal in 
the WT into a crankshaft in the Osaka mutant resulting in exposure of a dry surface 
in the WT to the solvent. Although the final structure from our simulations on the WT 
does not resemble the WT fibril of Aβ(42), the predicted effect of the deletion of 
Glu22 on the structure is in its nature the same as seen from the simulations in that 
surfaces that are interior become exterior and the gain of interaction model would 
seem to apply. As seen in Figure 9(B) two mutually shielding surfaces within a single 
WT subunit become exposed in the Osaka mutant allowing shielding to occur 
through protofilament association in a domain swapping process (Nelson and 
Eisenberg, 2006). This could explain the observation that the Osaka mutant forms a 
large network of fibrillar bundles in vitro (Ovchinnikova et al., 2011) rather than 
straight fibrils of the WT.
CONCLUSIONS
Analysis of simulation results on Aβ oligomers and experimental structures of Aβ 
fibrils has revealed the role played by half-turns in determining structure. It has been 
shown that only those half-turns, which create a ~90° bend in a strand enable the 
stacking of strands in the cross-β configuration. Thus, the right-angle fold seen in 
many fibril structures is an intrinsic feature of the cross-β configuration. At the fold all 
inter-strand hydrogen bond donors and acceptors are satisfied, suggesting a highly 
stable conformation. The pairwise combination rules for half-turns allow one to 
determine the general path of the backbone and suggest relatively simple rules could 
be applied for modelling Aβ fibrils. For example, a relatively short distance between 
two neighbouring half-folds that produce a reversal will enable side chains to inter-
lock in a steric zipper arrangement as seen in a number of fibril structures. If half-
turns occur at specific residues such as glycines, as strongly suggested by our 
simulations and indicated by the experimental results, then the 2D path will be 
largely determined by the position of glycines in the sequence. In the WT, Dutch and 
Iowa mutants all glycines, apart from the one closest to the C-terminal, are in-phase, 
which means the half-turns all fold to the same side creating a closed conformation. 
The out-of-phase positions of glycines in the Arctic and Osaka mutants explains their 
radically different final structures. Although there is obviously a large amount of 
variation in the 2D path seen in the deposited structures, these insights could 
provide a starting point for further analysis. Indeed, this insight has already provided 
us with a possible explanation of the Osaka mutant’s tendency to form of a network 
of fibrillar bundles in-vitro by protofilament association via a domain swapping 
process. 
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TABLE I RMSD of mutant final structures with WT final structure
RMSD of Cα atoms after superposition on residues indicated.
* RMSD is determined by fitting on corresponding residues.
TABLE 2 Half-turn rules
(a) Thumb of corresponding hand pointing in direction of N-H at residue i-1 (first β 
residue) and curl of fingers gives direction of turn (see Figure 7(A), (B) and (C).
(b) Even and odd refer to the number of intervening residues in the β conformation.
Mutant Whole protein 
RMSD (Å)
N-term RMSD 
(residues 1-21)  (Å)
C-term RMSD 
(residues 23-40)  (Å)
Dutch, E22Q 5.9 3.0 7.6
Iowa, D23N 7.2 3.5 9.6
Arctic, E22G 16.0 3.8 11.1
Osaka, E22Δ 18.7* 4.5 15.4*
Structural rules for individual half-turns
Half-turn type Turn direction(a) Phase change
βαRβ ~90° right-hand Yes
βαLβ ~90° left-hand Yes
βεβ ~90° left-hand No
Structural rules for pairs of half-turns














Figure 1: Cα-atom RMSD “colour-maps” between WT and each mutant over whole 
trajectories. Colour coding is indicated with RMSD values given in Å. The WT time 
axis is along the x-axis and the mutant time axis is along the y-axis. (A) WT and 
Dutch. (B) WT and Iowa. (C) WT and Arctic. (D) WT and Osaka.
Figure 2
Figure 2: Final structures from MD simulations.  (A) WT (B) Dutch (E22Q) (C) Iowa 
(D23N) (D) Arctic (E22G) (E) Osaka (E22Δ). The black arrows indicate locations of 
Glu22, Gln(22), Asn(23) and Gly22, shown in stick depiction, in (A), (B), (C) and (D), 
respectively, and the site of the deletion in (E). (F) Two views of the WT and Osaka 
mutant fitted on their N-terminal halves. Blue and cyan are the N-terminal and C-
terminal halves of the WT, respectively; red and magenta are the N-terminal and C-
terminal halves of the Osaka mutant, respectively. Glu22 in the WT is situated 
between the blue and cyan regions. The arrow is the screw axis for the movement of 
the C-terminal WT backbone to best fit with C-terminal backbone of the Osaka 
mutant. It rotates ~180° about and translates ~10 Å along the axis. Screw axis was 
determined using the “Domain Select” webserver at www.cmp.uea.ac.uk/dyndom   
(Lee et al., 2003).
Figure 3
Figure 3: Plots of  and  angles against residue number and amino acid single-
letter code for the WT, Dutch and Iowa (top half of figure) and for the WT, Arctic and 
Osaka (bottom half of figure). These are mean values averaged over chains C-I and 
the final 100 ns. Glycine positions common to all variants are indicated by the 
vertical broken black lines at positions 9, 25, 29, 33, 37 and 38. The vertical broken 
line in green is at position 22 and only occurs in the Arctic mutant. The horizontal 
broken black lines are at =-120° and =115.8° which are the values for the starting 
structures. The error bars show one standard deviation from the mean.
Figure 4
Figure 4: Part of WT structure showing pattern of bifurcated hydrogen bonds from 
the amide hydrogens of Val24-Gly25 and Lys28-Gly29 with the carbonyl oxygens of 
Asp23 and Asn27 on neighbouring strands, respectively. 
Figure 5
Figure 5: Alignment of WT and mutant sequences illustrating the phasing of glycines 
and fold directions. The grey and white columns indicate the alternating orientation of 
the residues along a β-strand. Glycines are indicated in red when on a grey residue 
and in blue when on a white residue. A change in the fold direction will occur at 
those locations where there is a change in colour of glycine. Ignoring the final glycine 
at position 38, for the WT, Dutch mutant and Iowa mutant there is no change in fold 
direction. For the Arctic mutant there are two changes of fold direction, one at Gly22 
and the other at Gly25. For the Osaka mutant there is a single change in fold 
direction at Gly25. 
Figure 6 
Figure 6: Ramachandran contour plots. The ,  angles (sampled in 2° intervals) 
are for the residue situated at the bend between the two β-strands flanking the bend. 
The darker the colour the lower the value. The white dots are at the model values (-
70°, -70°), (70°, 70°) and (150°, -150°) used here for αR, αL and ε, respectively.  (A) 
Contours of  as defined in Equation (1). Points at  (within small white 𝑆𝑃 𝑆𝑃 = 0
contours at  in the centre of the dark blue regions) are where the peptide 𝑆𝑃 = 0.001
planes of both β-strands are perpendicular to the plane defined by the two β-strands. 
(B) Contours of  as defined in Equation (2). The  contour in white is where 𝑆𝐵 𝑆𝐵 = 0
the angle between the two β-strands is 90°.
Figure 7
Figure 7: Half-turns in β-strands with β(,) = (-120°,115.8°), αR(,) = (-70°,-70°), 
αL(,) = (70°,70°) and ε(,) = (150°,-150°) . (A) Left-hand half-turn: ··· βαLβ··· (B) 
Right-hand half-turn: ··· βαRβ··· (C) Left-hand half turn: ··· βεβ··· (D) Two poly-
alanine strands with a βαRβ half-turn docked using the interactive docking tool, 
DockIT (Iakovou et al., 2020), showing all inter-strand hydrogen bonds (broken black 
lines), which includes those at the turn. (E) Similarly, for two poly-alanine strands 
with a βαLβ half-turn. (F) Similarly, for two poly-alanine strands with a βεβ half-turn 
but with the alanine at ε replaced by a glycine. (G) Example of a “reversal”: two right-
hand half-turns separated by four β: ···βαRββββαRβ···  (H) Example of a “crankshaft”: 
a right-hand half-turn and a left-hand half-turn separated by four β: ···βαRββββαLβ··· 
Figure 8
Figure 8: (A) Alignment of the half-turns in six Alzheimer Aβ structures labelled by 
their PDB codes. “N” and “C” denote the N-terminal and C-terminal residues, 
respectively. A blank space between the N and C indicates the β or a near β 
conformation; blanks exterior to N and C represent unresolved residues. “R” 
indicates the right-hand half-turn, βαRβ, “L”, the left-hand half-turn, βαLβ, and “E”, the 
left-hand half-turn, βεβ. The “X” in the 2MVX structure indicates the missing Glu 
residue in the Osaka mutant structure 2MVX. The structure of 2MPZ is the Iowa 
mutant and has Asn at 23 rather than Asp. The numbers in the half-turn sequences 
such as “10L2E12” indicate the number of residues in the β conformation before, 
between or after L, R, or E. Glycine positions are indicated with grey columns. (B-G) 
Simplified models derived from the half-turn sequences in (A) using the pairwise 
combination rules of Table 2 in comparison to backbone traces from the deposited 
PDB structures. (B) The 2BEG structure. (C) The Iowa mutant structure, 2MPZ. (D) 
The Osaka mutant structure, 2MVX. (E) The 2MXU structure. Inset is the half-turn 
sequence model which shows the structure folds in on itself. To achieve a structure 
close to the deposited one, the blue part rotates ~90° about a region in the first 
segment that contains a run of three residues that cannot be classified as β, αR, αL or 
ε. (F) The 5KK3 structure. Inset shows the half-turn sequence model which also folds 
in on itself. In order to achieve a structure close to the deposited one, the angles 
indicated in blue need to increase to ~120°. (G) The 5OQV structure.
Figure 9 
Figure 9: (A) Top: Half-turn sequence model of WT protofilament based on the 
5OQV structure as seen in Figure 8(G). The half-turn sequence is 9L12L1R8L2L5. 
Opposite sides of the structure are indicated in red and blue and interlocking side 
chains (steric zipper) are indicated. The C-terminal half is indicated in green. Bottom: 
Half-turn sequence model of predicted Osaka mutant based on half-turn sequence, 
9L11L1R8L2L5, of WT with Glu22 deleted. The green arrow indicates the screw axis 
about which the C-terminal half indicated in green rotates and translates in going 
from the WT to Osaka mutant. (B) Side chains from different protofilaments now 
interlock, joining protofilaments of the Osaka mutant model together in a domain 
swapping process.
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Highlights
 Structural determinants of Alzheimer’s Aβ fibril structures are investigated.
 Three types of half-turns, βαRβ, βαLβ and βεβ, are shown to be main 
determinants
 Right-angle fold in Aβ fibrils is shown to be due to cross-β structure 
 Half-turn pairwise combination rules determine backbone path and predict 
effect for Osaka mutant
 MD shows glycine phasing creates closed wild-type and S-shape Osaka 
mutant
